Nanosphere Signs Molecular Diagnostic Supply Agreement With HealthTrust

Nanosphere Signs Molecular Diagnostic Supply Agreement With HealthTrust

NORTHBROOK, Ill., June 23, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc.
(Nasdaq:NSPH), a company enhancing medicine through targeted molecular
diagnostics, today announced that it has been selected by HealthTrust as a
provider of multi-target molecular diagnostic tests for the nearly 1,400 acute
care facilities that are part of the HealthTrust membership.

Under this agreement, HealthTrust will offer its members access to purchase
Nanosphere's portfolio of Verigene® multiplex molecular diagnostic infectious
disease tests, including those designed to rapidly and accurately detect
infections of the bloodstream, respiratory tract and gastrointestinal tract.

The agreement became effective on June 1, 2014.

Please contact your local sales representative or info@nanosphere.us for
additional information.

About the Verigene® System

The Verigene System uses Nanosphere's core proprietary gold nanoparticle
chemistry to offer highly sensitive, highly specific molecular diagnostic
results through low-cost multiplexing. The Verigene System rapidly and
accurately detects infectious pathogens and drug resistance markers by
targeting conserved genetic regions of a bacterium or virus. Currently, the
multiplexed Verigene assays target infections of the blood, respiratory tract
and gastrointestinal tract. The information gathered from Verigene test
results enables clinicians to make informed patient treatment decisions more
quickly, which may result in improved patient outcomes, reduced costs,
optimized antibiotic therapy, and reduced spread of antibiotic resistance.

About Nanosphere, Inc.

Nanosphere is enhancing medicine through targeted molecular diagnostics that
result in earlier disease detection, optimal patient treatment and improved
healthcare economics. The Company's versatile technology platform, the
Verigene® System, enables clinicians to rapidly detect the most complex,
costly and deadly infectious diseases through a low cost and simple-to-use
multiplexed diagnostic test. The combination of this innovative technology and
Nanosphere's customer-driven solutions keeps commitment to the patient at the
forefront of its business. Nanosphere is based in Northbrook, IL. Additional
information is available at nanosphere.us.

About HealthTrust

HealthTrust (legally known as HealthTrust Purchasing Group, L.P.) is committed
to strengthening provider performance and clinical excellence through an
aligned membership model and the delivery of total cost management solutions,
including supply chain solutions and a contract and service portfolio
unparalleled in quality, scope and value. HealthTrust (www.healthtrustpg.com)
serves nearly 1,400 acute care facilities, 800 ambulatory surgery centers and
members in more than 10,600 other locations, including physician practices,
long-term care and alternate care sites. Headquartered in Brentwood,
Tennessee, HealthTrust is closely integrated with the proven capabilities of
Parallon Business Solutions, LLC (www.parallon.com), a leading provider of
healthcare business and operational services, including revenue cycle
management, workforce and technology solutions.

CONTACT: Investors:
         Roger Moody, Chief Financial Officer
         847-400-9021
         rmoody@nanosphere.us
        
         Michael Rice, LifeSci Advisors
         646-597-6979
         mrice@lifesciadvisors.com
        
         Media:
         Lindsey Saxon, Director of Communications
         847-400-9173
         lsaxon@nanosphere.us
 
Press spacebar to pause and continue. Press esc to stop.